Ad Hoc Working Group on acellular pertussis vaccines, World Health Organisation, Geneva, 27-28 July 2000

Vaccine

Volumn 20, Issue 3-4, 2001, Pages 288-291

  Corbel, M J ^a   Mastrantonio, P ^b   Kreeftenberg, J G ^c  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

JNIH3 VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; VACCINE;

BIOASSAY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MEDICAL RESEARCH; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SWITZERLAND; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION;

HUMANS; PERTUSSIS VACCINE; VACCINES, ACELLULAR; WORLD HEALTH ORGANIZATION;

EID: 0035851321     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00343-7     Document Type: Conference Paper

References (1)

1. Informal consultation with manufacturers and the Ad Hoc Working Group on mouse protection models for acellular pertussis vaccines